EV71灭活疫苗（人二倍体细胞）在恒河猴婴猴模型中的免疫保护性分析

肠道病毒71型作为引起儿童群体常见传染性手足口病（HFMD）的主要病原,具有导致少量感染个体出现脑炎等神经系统病变以及相关心肺功能衰竭的病理学特性．因此其预防性疫苗的研发具有重要的公共卫生意义．在前期工作的基础上,一种EV71灭活病毒疫苗（人二倍体细胞）在本研究中基于恒河猴婴猴模型进行了相应的免疫保护性分析．以160EU剂量对2～3月龄婴猴进行0,4周免疫后,动物在第4周接受了剂量为10。～CCID50的病毒经呼吸道的攻击．对病毒攻击后动物在14天内的临床症状、血液生物学、器官病原学分布以及病理学检测的动态观察表明,经疫苗免疫的动物未出现对照动物所具有的特征性临床表现,其血液生物学及病理学检测均无异常．同时,器官病原学分布亦呈阴性．结合动物中和抗体的明确增长及对照动物的综合表现分析,本文的工作证实了该EV71灭活病毒疫苗（人二倍体细胞）在恒河猴婴猴体内的免疫保护性．     

茎花葱臭木化学成分的研究

从茎花葱臭木种子中分离得到5个化合物,经理化与波谱分析鉴定为β-谷甾醇(1)、没食子酸乙酯(2)、胡萝卜苷(3)、1-O-β-D-吡喃葡萄糖基-(2S,3S,4R,8Z)-2-N-(2 ′-羟基二十四烷酰氨基)十八二氧鞘氨-8-烯(4)和2,3,2″,3″-四氢穗花杉双黄酮(5).这5个化合物均首次从该植物中分离得到.其中化合物5进行细胞毒活性测试,没有显示抑制活性.     

非生物胁迫下植物表观遗传变异的研究进展

植物在整个生命过程中固着生长,不能主动躲避外界不良环境的危害,需要通过自身的防御机制来抵御和适应外界胁迫,而表观遗传修饰在调控植物应对不良环境胁迫中起重要作用。该文从DNA甲基化、组蛋白修饰、染色质重塑和非编码RNA等方面进行了综述,主要阐述了近年来国内外有关非生物胁迫下植物的表观遗传变化,以期为利用表观遗传变异提高植物的抗胁迫能力提供参考。     

不同种源中间锦鸡儿碳氮磷化学计量特征研究

中间锦鸡儿(Caragana liouana)是中国毛乌素沙地的主要灌木建群种,在其主要分布区采集9个不同地理种源的种子,栽种至同质园,并测定不同器官(根、茎、叶)碳(C)、氮(N)、磷(P)含量,比较种源和器官间碳氮磷化学计量特征的差异及元素之间的相关性。结果显示:(1)不同种源中间锦鸡儿根、茎、叶的C含量差异显著,分别为361.12~426.30mg·g~(-1)、412.32~463.13mg·g~(-1)、419.21~478.94mg·g~(-1);N含量种源间差异显著,分别为20.52~33.67mg·g~(-1)、15.77~23.92mg·g~(-1)、27.60~36.44mg·g~(-1);P含量种源间差异显著,分别为1.52~3.73mg·g~(-1)、1.24~2.14mg·g~(-1)、1.44~2.38mg·g~(-1);不同器官的C/N、C/P、N/P也表现出种源间显著差异。(2)种源和器官对中间锦鸡儿碳氮磷化学计量特征的影响程度存在差异,种源对P、C/P、N/P影响较大,器官对C、N、C/N影响较大。(3)相关性分析表明,N、P分别对C/N和C/P的变异起主导作用,并共同影响N/P的变异。研究表明,中间锦鸡儿的碳氮磷化学计量特征在长期的适应进化过程中已产生遗传分化,并形成了自身的养分利用策略。     

内蒙古草原人类福祉与生态系统服务及其动态变化——以锡林郭勒草原为例

以锡林郭勒盟为研究区域,建立人类福祉评价指标体系,通过牧户问卷调查了解牧户对草原生态系统服务和福祉变化的认识,结合当地的自然环境、生态环境和社会经济等多方面的多年统计数据,采用专家打分法对牧民各福祉指标打分,对2001年和2010年牧民福祉变化进行了评估和分析。结果表明:收入、道路覆盖率、农村合作医疗保险和文化教育方面对牧民福祉变化贡献最大;生产资料持续供给能力下降是导致收入减少的主要方面;旗县的犯罪率,环境空气质量,饮食结构,离婚率等是导致牧民福祉下降的主要方面。有关研究结果为提高锡林郭勒盟人类福祉、生态保护和区域可持续发展政策制定提供科学依据。     

基于Voronoi图的丹顶鹤巢址空间格局分析

依据1996年、2003—2007年扎龙保护区丹顶鹤巢址数据,利用Voronoi图理论,分析了巢址的空间分布特征,计算了其拓扑指数—Voronoi图面积。结果表明,丹顶鹤巢址空间分布具有明显的空间聚类特征。以扎龙保护区的2006年巢址、居民点、国道和铁路为对象,构成其Voronoi图,较好地说明了人类活动对丹顶鹤巢址的空间格局的影响,研究结果对丹顶鹤栖息地的保护将起到重要作用。     

复方环丙酮胺治疗浅部真菌病的疗效观察

观察复方环丙酮胺喷剂治疗浅部真菌病的疗效。第Ⅰ批给予复方环丙酮胺喷剂,1次/d喷于患处,用药4周后观察疗效;第Ⅱ批随机入A、B组,A组给予复方环丙酮胺喷剂+曲安奈德喷剂,B组给予复方环丙酮胺喷剂,均1次/d喷于患处,用药2周、4周后观察疗效。第Ⅰ批治疗4周总有效率为80%;第Ⅱ批A、B组治疗2周总有效率分别为75%及82.35%,治疗4周总有效率分别为94.74%及100%。复方环丙酮胺喷剂和复方环丙酮胺喷剂+曲安奈德喷剂治疗浅部真菌病的疗效相似(P>0.05),且疗效显著、局部刺激小、瘙痒缓解明显、安全性较高。     

大鼠脑缺血再灌注后血清中血管内皮生长因子与神经元凋亡的研究

目的:通过检测SD大鼠脑缺血再灌注模型血清中血管内皮生长因子(VEGF)与神经元凋亡动态表达变化的关系,以探讨两者之间的相关性。方法:将40只大鼠随机分为8组:对照组、假手术组和脑缺血30min再灌注12h组、1d组、3d组、5d组、7d组、及14d组,每组5只。采用ELISA双抗夹心法检测大鼠血清中血管内皮生长因子、原位细胞凋亡TUNEL法检测脑组织中的凋亡神经细胞数。结果:再灌注12h、1d、3d、5d、7d及14d大鼠血清VEGF表达和凋亡神经元百分比的变化均为负相关性(均为P<0.05)。结论:在脑缺血再灌注大鼠模型中,缺血诱导使VEGF的表达发生变化,VEGF通过直接或间接的途径抑制神经元凋亡。     

Using Data-Driven Model-Brain Mappings to Constrain Formal Models of Cognition

In this paper we propose a method to create data-driven mappings from components of cognitive models to brain regions. Cognitive models are notoriously hard to evaluate, especially based on behavioral measures alone. Neuroimaging data can provide additional constraints, but this requires a mapping from model components to brain regions. Although such mappings can be based on the experience of the modeler or on a reading of the literature, a formal method is preferred to prevent researcher-based biases. In this paper we used model-based fMRI analysis to create a data-driven model-brain mapping for five modules of the ACT-R cognitive architecture. We then validated this mapping by applying it to two new datasets with associated models. The new mapping was at least as powerful as an existing mapping that was based on the literature, and indicated where the models were supported by the data and where they have to be improved. We conclude that data-driven model-brain mappings can provide strong constraints on cognitive models, and that model-based fMRI is a suitable way to create such mappings.     

Clinical Burkholderia pseudomallei isolates from north Queensland carry diverse bimABm genes that are associated with central nervous system disease and are phylogenomically distinct from other Australian strains

BackgroundBurkholderia pseudomallei is an environmental gram-negative bacterium that causes the disease melioidosis and is endemic in many countries of the Asia-Pacific region. In Australia, the mortality rate remains high at approximately 10%, despite curative antibiotic treatment being available. The bacterium is almost exclusively found in the endemic region, which spans the tropical Northern Territory and North Queensland, with clusters occasionally present in more temperate climates. Despite being endemic to North Queensland, these infections remain understudied compared to those of the Northern Territory.Methodology/Principal findingsThis study aimed to assess the prevalence of central nervous system (CNS) disease associated variant bimA_Bm, identify circulating antimicrobial resistance mutations and genetically distinct strains from Queensland, via comparative genomics. From 76 clinical isolates, we identified the bimA_Bm variant in 20 (26.3%) isolates and in 9 (45%) of the isolates with documented CNS infection (n = 18). Explorative analysis suggests a significant association between isolates carrying the bimA_Bm variant and CNS disease (OR 2.8, 95% CI 1.3–6.0, P = 0.009) compared with isolates carrying the wildtype bimA_Bp. Furthermore, 50% of isolates were identified as novel multi-locus sequence types, while the bimA_Bm variant was more commonly identified in isolates with novel sequence types, compared to those with previously described. Additionally, mutations associated with acquired antimicrobial resistance were only identified in 14.5% of all genomes.Conclusions/SignificanceThe findings of this research have provided clinically relevant genomic data of B. pseudomallei in Queensland and suggest that the bimA_Bm variant may enable risk stratification for the development CNS complications and be a potential therapeutic target.